Mohammad "Haroon" Choudry MD

Summary

• I am currently an Associate Professor of Surgery in the Division of Surgical Oncology, Department of Surgery, at the University of Pittsburgh Medical Center. I completed my surgical residency training at Penn State University Medical Center and Surgical Oncology fellowship at the University of Pittsburgh Medical Center. I have a broad clinical practice that includes primary gastrointestinal malignancies, sarcomas, melanomas, neuroendocrine tumors, as well as some hepato-pancreato-biliary surgery. I have significant experience with laparoscopic and robotic surgery. I have a particular interest in the management of patients with peritoneal surface malignancies and peritoneal metastases, including cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion. I lead my own NIH-funded basic science/ translational research laboratory. The overall goal of my research has been to elucidate the role of mucin 2 (MUC2) protein in the tumor biology of mucinous colorectal and appendix cancer, determine whether modulation of mechanisms associated with MUC2 protein production impacts tumor growth and chemosensitivity, and identify novel mucin-inhibitory and mucolytic agents that may be translated to clinical trials. At a national level, I serve as an editorial board member in the Gastrointestinal Oncology Section of the Annals of Surgical Oncology, the official journal of the Society of Surgical Oncology. I was nominated to the Society of Surgical Oncology Task Force Committee tasked with creating clinical pathways and billing/coding standards for peritoneal surface malignancies in 2018. I was also nominated to the Society of Surgical Oncology peritoneal surface malignancy working group in 2018 tasked with developing and expanding educational initiatives, developing cross-collaborations, and improving clinical care for such diseases.